217 related articles for article (PubMed ID: 21625209)
1. Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.
Liu RY; Dong Z; Liu J; Yin JY; Zhou L; Wu X; Yang Y; Mo W; Huang W; Khoo SK; Chen J; Petillo D; Teh BT; Qian CN; Zhang JT
Oncogene; 2011 Dec; 30(48):4814-23. PubMed ID: 21625209
[TBL] [Abstract][Full Text] [Related]
2. eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation.
Zhang Y; Yu JJ; Tian Y; Li ZZ; Zhang CY; Zhang SF; Cao LQ; Zhang Y; Qian CY; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2015 Sep; 6(28):25441-51. PubMed ID: 26213845
[TBL] [Abstract][Full Text] [Related]
3. EZH2 suppresses the nucleotide excision repair in nasopharyngeal carcinoma by silencing XPA gene.
Huang Y; Wang X; Niu X; Wang X; Jiang R; Xu T; Liu Y; Liang L; Ou X; Xing X; Li W; Hu C
Mol Carcinog; 2017 Feb; 56(2):447-463. PubMed ID: 27253463
[TBL] [Abstract][Full Text] [Related]
4. eIF3a regulation of mTOR signaling and translational control via HuR in cellular response to DNA damage.
Ma S; Dong Z; Huang Y; Liu JY; Zhang JT
Oncogene; 2022 Apr; 41(17):2431-2443. PubMed ID: 35279705
[TBL] [Abstract][Full Text] [Related]
5. MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway.
Fang C; Chen YX; Wu NY; Yin JY; Li XP; Huang HS; Zhang W; Zhou HH; Liu ZQ
Sci Rep; 2017 Jan; 7():40384. PubMed ID: 28074905
[TBL] [Abstract][Full Text] [Related]
6. Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair.
Yin JY; Shen J; Dong ZZ; Huang Q; Zhong MZ; Feng DY; Zhou HH; Zhang JT; Liu ZQ
Clin Cancer Res; 2011 Jul; 17(13):4600-9. PubMed ID: 21610145
[TBL] [Abstract][Full Text] [Related]
7. O(6) -methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma.
Chen SH; Kuo CC; Li CF; Cheung CH; Tsou TC; Chiang HC; Yang YN; Chang SL; Lin LC; Pan HY; Chang KY; Chang JY
Int J Cancer; 2015 Sep; 137(6):1291-305. PubMed ID: 25693518
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways.
Pan Y; Zhang Q; Atsaves V; Yang H; Claret FX
Oncogene; 2013 May; 32(22):2756-66. PubMed ID: 22797071
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
[TBL] [Abstract][Full Text] [Related]
10. MTA1 overexpression induces cisplatin resistance in nasopharyngeal carcinoma by promoting cancer stem cells properties.
Feng X; Zhang Q; Xia S; Xia B; Zhang Y; Deng X; Su W; Huang J
Mol Cells; 2014 Sep; 37(9):699-704. PubMed ID: 25245523
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells.
Liu RY; Dong Z; Liu J; Zhou L; Huang W; Khoo SK; Zhang Z; Petillo D; Teh BT; Qian CN; Zhang JT
Mol Cancer Ther; 2013 Oct; 12(10):2157-66. PubMed ID: 23956056
[TBL] [Abstract][Full Text] [Related]
12. Identification Keratin 1 as a cDDP-resistant protein in nasopharyngeal carcinoma cell lines.
Tang S; Huang W; Zhong M; Yin L; Jiang H; Hou S; Gan P; Yuan Y
J Proteomics; 2012 Apr; 75(8):2352-60. PubMed ID: 22348822
[TBL] [Abstract][Full Text] [Related]
13. BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.
Kuang CM; Fu X; Hua YJ; Shuai WD; Ye ZH; Li Y; Peng QH; Li YZ; Chen S; Qian CN; Huang W; Liu RY
Cell Death Dis; 2017 Jun; 8(6):e2874. PubMed ID: 28617432
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
Yin P; Song G; Jiang Z
Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of NFBD1/MDC1 enhances chemosensitivity to cisplatin or 5-fluorouracil in nasopharyngeal carcinoma CNE1 cells.
Zeng Q; Wang Z; Liu C; Gong Z; Yang L; Jiang L; Ma Z; Qian Y; Yang Y; Kang H; Hong S; Bu Y; Hu G
Mol Cell Biochem; 2016 Jul; 418(1-2):137-46. PubMed ID: 27334757
[TBL] [Abstract][Full Text] [Related]
16. Reversal of cisplatin sensitization and abrogation of cisplatin-enriched cancer stem cells in 5-8F nasopharyngeal carcinoma cell line through a suppression of Wnt/β-catenin-signaling pathway.
Sinnung S; Janvilisri T; Kiatwuthinon P
Mol Cell Biochem; 2021 Apr; 476(4):1663-1672. PubMed ID: 33423190
[TBL] [Abstract][Full Text] [Related]
17. N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion.
Lane DJ; Saletta F; Suryo Rahmanto Y; Kovacevic Z; Richardson DR
PLoS One; 2013; 8(2):e57273. PubMed ID: 23437357
[TBL] [Abstract][Full Text] [Related]
18. Comparative Proteomic Profiling of Cisplatin-resistant Nasopharyngeal Carcinoma Cell Lines: Novel Biomarkers for Improving Chemotherapy of NPC.
Prathaphan P; Reamtong O; Ngaokrajang U; Janvilisri T; Swainson NM; Kiatwuthinon P
Anticancer Res; 2022 Jul; 42(7):3507-3522. PubMed ID: 35790268
[TBL] [Abstract][Full Text] [Related]
19. eIF3a Regulation of NHEJ Repair Protein Synthesis and Cellular Response to Ionizing Radiation.
Tumia R; Wang CJ; Dong T; Ma S; Beebe J; Chen J; Dong Z; Liu JY; Zhang JT
Front Cell Dev Biol; 2020; 8():753. PubMed ID: 32974334
[TBL] [Abstract][Full Text] [Related]
20. O6-methylguanine-DNA methyltransferase modulates cisplatin-induced DNA double-strand breaks by targeting the homologous recombination pathway in nasopharyngeal carcinoma.
Chen SH; Huang WT; Kao WC; Hsiao SY; Pan HY; Fang CW; Shiue YL; Chou CL; Li CF
J Biomed Sci; 2021 Jan; 28(1):2. PubMed ID: 33397362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]